P.1.030 Double-blind, placebo-controlled,multicenter study evaluating nemifitide, a new pentapeptide antidepressant, when given daily or every other day for three weeks in the treatment of major depressive disorder

Autor: Feighner, J.P., Sverdlov, L., Hlavka, J., Nicolau, G., Tonelli, G., Freed, J.
Zdroj: In European Neuropsychopharmacology 2005 15 Supplement 2:S119-S119
Databáze: ScienceDirect